Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale

Risk of Ischaemic Stroke After Pulmonary Embolism in Patients With and Without Patent Foramen Ovale (29BRC21.0082)

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT04987008

Acronym

EPIC-FOPCohort

Enrollment

Registered

2021-08-03

Start date

2021-05-18

Completion date

2021-08-31

Last updated

2021-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Foramen Ovale, Patent

Keywords

foramen ovale, patent, stroke, pulmonary embolism

Brief summary

stroke's risk is increased in patients with pulmonary embolism and PFO compared to patients without PFO. Does this increased risk persist years after pulmonary embolism ?

Detailed description

324 patients included in EPIC-FOP study (2009 to 2015) were followed annually to collect data about the recurrence of VTE, cardiovascular events and treatments.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

RETROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Inclusion criteria

* patients included in EPIC-FOP study

Exclusion criteria

* refusal to participate

Design outcomes

Primary

Measure	Time frame	Description
stroke	pulmonary embolism (2009 to 2015) to 2021	documented stroke

Secondary

Measure	Time frame	Description
TIA or stroke	pulmonary embolism (2009 to 2015) to 2021	documented TIA or stroke
death	pulmonary embolism (2009 to 2015) to 2021	all deaths and cardiovascular deaths
bleeding	pulmonary embolism (2009 to 2015) to 2021	Major and clinically pertinent bleeding (ISTH classification)
VTE	pulmonary embolism (2009 to 2015) to 2021	recurrent VTE

Countries

France

Contacts

Primary ContactEmmanuelle LE MOIGNE

emmanuelle.lemoigne@chu-brest.fr0298347344

Outcome results